Search

Your search keyword '"Wacker, Anna"' showing total 143 results

Search Constraints

Start Over You searched for: Author "Wacker, Anna" Remove constraint Author: "Wacker, Anna"
143 results on '"Wacker, Anna"'

Search Results

2. 1H, 13C and 15N chemical shift assignment of the stem-loops 5b + c from the 5′-UTR of SARS-CoV-2

5. Structure of an internal loop motif with three consecutive U•U mismatches from stem–loop 1 in the 3′-UTR of the SARS-CoV-2 genomic RNA

7. Dissecting the Conformational Heterogeneity of Stem-Loop Substructures of the Fifth Element in the 5′-Untranslated Region of SARS-CoV-2

8. 1H, 13C, 15N and 31P chemical shift assignment for stem-loop 4 from the 5′-UTR of SARS-CoV-2

9. 1H, 13C and 15N assignment of stem-loop SL1 from the 5'-UTR of SARS-CoV-2

11. 1H, 13C and 15N chemical shift assignment of the stem-loop 5a from the 5′-UTR of SARS-CoV-2

12. Comprehensive Fragment Screening of the SARS‐CoV‐2 Proteome Explores Novel Chemical Space for Drug Development

13. m6A Methylation of Transcription Leader Sequence of SARS‐CoV‐2 Impacts Discontinuous Transcription of Subgenomic mRNAs.

16. Das COVID19‐NMR‐Konsortium: Ein öffentlicher Bericht über den Einfluss dieser neuen globalen Kollaboration

19. NMR 1H,19F-based screening of the four stem-looped structure 5_SL1–SL4 located in the 5′-untranslated region of SARS-CoV 2 RNAElectronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3md00322a

20. NMR characterization and ligand binding site of the stem–loop 2 motif from the Delta variant of SARS-CoV-2

21. Comprehensive Fragment Screening of the SARS‐CoV‐2 Proteome Explores Novel Chemical Space for Drug Development

22. Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development

24. Exploring the druggability of conserved RNA regulatory elements in the SARS-CoV-2 genome

25. Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS‐CoV‐2 Genome

28. Correction to ‘Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy’

29. In-cell NMR spectroscopy of functional Riboswitch aptamers in eukaryotic cells

30. 19F NMR-based fragment screening for 14 different biologically active RNAs and 10 DNA and protein counter-screens

31. Correction to 'Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy’

32. No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial

33. Characterization of structure and dynamics of the guanidine-II riboswitch from Escherichia coli by NMR spectroscopy and small-angle X-ray scattering (SAXS)

37. Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy

38. 19 F NMR‐Based Fragment Screening for 14 Different Biologically Active RNAs and 10 DNA and Protein Counter‐Screens

40. 1H, 13C, and 15N backbone chemical shift assignments of coronavirus-2 non-structural protein Nsp10

41. 1H, 13C, and 15N backbone chemical shift assignments of the apo and the ADP-ribose bound forms of the macrodomain of SARS-CoV-2 non-structural protein 3b

42. Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy

43. Die Hamburger HafenCity - Leben (in) der Zukunft?

44. 19F NMR‐Based Fragment Screening for 14 Different Biologically Active RNAs and 10 DNA and Protein Counter‐Screens.

46. Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes

48. Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes

49. Pausing guides RNA folding to populate transiently stable RNA structures for riboswitch-based transcription regulation

50. Author response: Pausing guides RNA folding to populate transiently stable RNA structures for riboswitch-based transcription regulation

Catalog

Books, media, physical & digital resources